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(AV delay hysteresis: AVDH). More recently, new modes of pacing were pro-
posed: MVP™ mode (Managed Ventricular Pacing) Medtronic-USA. The aim
of this study was to evaluate the gain of spontaneous conduction between dif-
ferent generations of AVDH and the MVP™ mode.
Methods: we studied two populations of patients implanted for conduction
disorder (CD) or sinus dysfunction (SD) distributed in three groups. 
Group I : 115 patients implanted with Kappa® series PM (Medtronic-USA)
and first generation AVDH (AVDH, CD : 56%, SD : 44%). 
Group II: 168 patients implanted with Enpulse® series PM (Medtronic-USA)
and 2nd generation AVDH (AVDH+, CD: 52%, SD: 48%). 
Group III: 156 patients implanted with Adapta® series PM (Medtronic-USA)
and the MVP™ mode (CD: 40%, SD: 60%). 
Populations were not different in sex, age and pacing indications. Patients who
presented less than 1% of spontaneous ventricular activity were excluded from
analysis. We compared first the gain in ventricular detection induced by
AVDH vs. AVDH+ and secondly the percentage of ventricular pacing
between AVDH+ and MVP in the two populations (Mood’s median test).
Results: shown in the following table:
Conclusion: AVDH+ results in a decrease in VP in patients without con-
duction disorder but not in patients with conduction disorder. The use of
MVP™ results in a significant decrease of ventricular pacing compared to first
and second generation of AVDH algorithms in both patients with or without
conduction disorder with a high gain in spontaneous AV conduction.
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Methods: The multicenter observational Generation MVP™ study
included 224 patients aged 77 + / - 10 years (men: 53%) implanted for sinus
dysfunction (SD) or brady-tachy syndrome (SBT) (n = 116) or atrio-ventric-
ular block (AVB) (n = 108). Programming function MVP™ has been left to
the discretion of the physician. Percentage of ventricular pacing and per-
centage of patients with paroxystic or persistent atrial arrhythmias was
assessed at 9 months on average according to the indication of pacing and the
state of programming function MVP™. 
Results: Percentage of ventricular pacing at 9 months is significantly lower
for the 2 groups of indication for patients with MVP™ function activated [On]
compared with patients without function MVP™ [Off]. Comparisons groups
were made by the Mood’s median test.  
Percentage of patients with atrial arrhythmias at 9 months was significantly
lower when the MVP™ function is programmed to [On] only in the AVB
group.
Conclusion: In this study in current practice, at 9 months follow-up pro-
gramming function MVP™ is associated with a significant decrease of ven-
tricular pacing for indications of SD-BTS and AV block. Moreover
programming function MVP™ is associated with a significant decrease of per-
centage of patients with atrial arrhythmias for AVB indications.
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Purpose: Right ventricular (RV) apex pacing is associated with LV dys-
synchrony. Alternate RV pacing sites (mid RV septum; the RV outflow tract
(RVOT)) were considered, with no clear benefit. The aim of this study is to
find a reliable method of septal lead placement ant to identify those pacing
sites which provide a better LV electrical activation.
Methods: 50 consecutive patients reffered for  pacemaker implants due to
AV block were included. Patients with history of heart failure or LVEF<50%
at implant were excluded. All patients had RV leads placed in septal position.
RV septum and RVOT were mapped during implant searching for the nar-
rowest paced QRS with an axis as close to normal as possible. Pacing lead
position was evaluated during implant using fluoroscopy (AP and LAO 40º)
and than by 12 lead ECG and echo. Intra LV dyssinchrony was evaluated
during pacing using SPWMD in parasternal short axis view and TDI septal to
lateral t. Paced QRS duration and axis were also recorded. A correlation was
sought between lead position evaluated by Rx and by echo and between paced
QRS duration and axis and LV dyssunchrony.
Results: 92%(46) of the patients had the RV lead in septal position (32 in
mid RV and 14 in RVOT) while 8% (4 pts) had the RV lead on the RVOT
free wall as shown by echo. An anteriorly oriented lead in the left anterior
oblique fluoroscopic projection was specific for free wall position while a pos-
itive QRS in DI in RVOT position was suggestive for free wall position on the
ECG. No correlation was made between paced QRS axis and LV dyssinchron.
A QRS duration of>160 ms was associated with significant LV dyssinchrony
(SPWMD>130 ms and septal to lateral t>70 ms).
Conclusions: RV lead placement on the RV septum can be reliably
achieved using a specialy shaped stilet and LAO projection for confirmation.
A wide paced QRS is correlated with significant intra LV dyssinchrony and
therefore the pacing site with the narrowest QRS should be sought.
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Background: The mechanisms of action of cardiac resynchronisation
therapy (CRT) and the predictive factors to CRT’s effect are not well known.
The mechanical left intra-ventricular dysynchrony (LIVD) has  a important
physiopathological role in severe left ventricular dysfunction with wide QRS.
Several studies compared  LIVD before and just after CRT implant but few
data are available about LIVD in the mid to long term.
 AVDH  AVDH (+)  MVP
 % VP with conduction disorder
Médian 99.7 N.S. 99.7 p < 0.001 15.0
1st , 3rd quart 97.1 - 99.8 66.1 - 100 1.4 - 79.2
 % VP without conduction disorder
Médian 78.5 p < 0.001 25.8 p < 0.001 1.8
1st , 3rd quart 43 - 95.1 6.9 - 72.7 1.3 - 5.6
Indication SD - BTS (n = 116) AVB (n = 108)
 MVP Off p MVP 
On
MVP 
Off
p MVP On
Number of pts 19  97 39  69
% VP 79% < 0.001 1% 99% < 0.001 15%
médian
1ier- 3ième Quart 13.5 - 99.6  0.3 - 5.6 99 - 100  0.4 - 75.6
% pts in AA 26% NS 19% 23% < 0.05 6%
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Methods and Results: We included prospectively the 42 consecutive
patients (younger than 75 yo) implanted in the University Hospital of Tou-
louse with ACC/AHA/ESC indications for CRT. Characteristics of the popu-
lation were: male sex 88%, ischemic cardiomyopathy 45%, mean  LVEF 22%,
mean QRS duration 160ms, CRT-D 98%. The echocardiographic (Pulsed
Doppler and Tissue Doppler Imaging) parameters of cardiac dysynchrony
were obtained at baseline and six month (or more) after CRT implant. We
defined the responder group as an improvement in 1 NYHA class and no hos-
pitalisation for heart failure (HF) during the follow up (mean duration 15
month). 62% (n=26) were clinical responders. The echocardiographic assess-
ment was done at 11 (6 to 20) month. There was no statistically significant
difference between the “residual” mechanical dysynchrony of the responders
versus the non-responders. Considering only the responders, there is no reduc-
tion of LIVD at six month after CRT. A baseline aortic pre-ejection delay >
140 ms, a non ischemic cardiomyopathy  and the left ventricular activation
time measured before implantation  with a method described recently by
Sweeney et al are the only factors of response to CRT.
Conclusions: The clinical response to CRT is not well correlate with the
“residual” mechanical LIVD such as we measured by echocardiography (DTI
and PD).
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Background: Cardiac Resynchronization Therapy (CRT) improves mor-
bidity and mortality in systolic heart failure. Elderly patients are under repre-
sented in large clinical trials although incidence of heart failure is high in this
population.
Method: we considered 146 consecutive patients  75 years old with stan-
dard indication for CRT implanted between 2005 and 2007. Mean age was 79
yo, 72 % males, EF= 27%, ischemic heart disease (IHD) 46%, Atrial Fibrilla-
tion 54%, CRT-D: 16%. Minimal follow-up was 12 months.  Total mortality,
clinical improvement (gain > 1 NYHA class without hospitalization for con-
gestive heart failure) and combined criteria (mortality and clinical improve-
ment) were retrospectively assessed.
Results: Mean follow-up is 25 +/-12 months. Data are complete for 137
patients (94.2%).
Survival rate is 65%, clinical improvement is achieved in 51% and combined
criteria in 45%.
Independent factors of non response (p<0.10) are summarized in the table.
Causes of deaths are: terminal heart failure: 35 pts, sudden cardiac death: 1 pt,
non cardiac death: 13 pts and unknown: 2 pts.
Conclusion: CRT is effective in elderly patients. Factors of non response
are similar to those observed in younger population. CRT-P appears to be the
most suitable device for this population.
(Voir tableau ci-dessous) 
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Objective: To assess whether LV mechanical dyssynchrony may be used
to predict response to CRT in patients with narrow QRS complex (<120ms).
Methods: CRT was performed in 183 symptomatic heart failure patients
(64±12 years, EF=25±8%) with narrow (n=41) and wide QRS complex
(n=142). Mechanical dyssynchrony before CRT implantation was quantified
by the 12 segment standard deviation of peak longitudinal strain by speckle
tracking (12SD) and the strain delay index (SDI) defined as the sum of differ-
ence between end systolic and peak strain across the 16 segments. 
Results: Before CRT, wide and narrow QRS patients had similar 12SD
(100±32ms vs. 105±35ms) and SDI (36±14% vs. 38±15%). However, in wide
QRS patients, QRS duration decreased after CRT (143±35ms vs. 120±34ms,
p<0.0001) and ESV reduction (mean= -21%, ESVR>15% in 66%, 92/139)
correlated with SDI (r=0.41, p<0.0001) and 12SD (r=0. 21, p=0.01) before
CRT. In contrast, in narrow QRS population, QRS duration increased after
CRT (96±16ms vs. 108±28ms, p=0.006) and ESV reduction (Mean=-11%,
ESVR>15% in 39% (25/41) failed to correlate with mechanical dyssynchrony
before CRT. Importantly, increase in QRS duration after CRT in narrow QRS
population was associated with adverse remodeling (r=0.43, p=0.01) and
tended to correlate with an increase in SDI after CRT (r=0.32, p=0.08). 
Conclusion: Response to CRT does not correlate to the importance of
mechanical dyssynchrony in narrow QRS population. The benefice of CRT
despite a significant LV dyssynchrony appears counterbalanced by a signifi-
cant QRS enlargement after CRT implantation in narrow QRS population. 
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Background: Cardiac resynchronisation therapy (CRT) has been shown to
improve clinical status in heart failure patients. Some patients treated by CRT
fail to respond to the treatment. Predisposing factors for non-response should
be investigated to optimize patient selection. 
Objective: The purpose of the study was to evaluate before device implan-
tation and 3, 6 and 12 month after, echocardiographic and biological parame-
ters with respect to  CRT response. 
Methods: Thirty two patients with heart failure (72% of men ; age 66 ± 10
years; 59 % non-ischaemic cardiomyopathy; NYHA III-IV; left ventricular
ejection fraction (LVEF) 22.7 ± 6.7 %; QRS width 146 ± 26 ms) were
implanted with CRT device and followed during twelve month. Responders
Multivariate analysis
OR (IC 95%)
Combined criteria Total
Mortality 
Clinical improvement
NYHA IV
IHD
CRT-D 
Atrial fibrillation
No ACEI /ARB
Renal failure ( creatinine > 10µm/l)
Doses of diuretics 
4,1 (1.5-12.4)
2,2 (1-4.8)
NS
2,7 (1.3-5.8)
2,7 (0.9-8.8)
1,1 (1-1.2)
NS
3.1 (1.2-8.5)
3.4 (1.5-7.9)
3.2 (1.2-8.8)
2.2 (1-5.1)
NS
NS
1.03 (1-1.1)
2.5 (1-6.6)
NS
NS
NS
NS
1.2 (1.1-1.3)
NS
